November 16, 2011

11:15 a.m. – 1:00 p.m.

Caring for Older Adults with T2DM: Best Practices Across the Continuum of Care

Activity # 0203-9999-11-110-L01-P; 1.5 contact hours

Speakers:

Susan Cornell, PharmD, CDE, FAPHA, FAADE

Assistant Director, Department of Pharmacy Practice

Midwestern University Chicago College of Pharmacy

Scott Drab, PharmD, CDE, BC-ADM

Assistant Professor of Pharmacy & Therapeutics

University of Pittsburgh School of Pharmacy

Hennie Garza, MS, RPh, CDE

Clinical Assistant Professor of Pharmacy Practice - Geriatrics

Texas Tech School of Pharmacy

The armamentarium of antidiabetic agents continues to grow with the emergence of several new agents to help providers and patients reach and maintain glycemic control. This activity will provide foundational knowledge on the risks associated with poor glycemic control and the strategies to achieve glycemic targets.

Learning Objectives

Upon completion of this knowledge-based activity, the participant will be able to:

• Recognize the importance of appropriate goal-setting in older adults with T2DM
• Evaluate treatment options for older adults with type 2 diabetes and consider their impact on comorbid disease
• Implement practical strategies to defeat persistent barriers to effective insulin treatment
• Compare the therapeutic profiles of incretin-based therapies and the safe use of these agents, particularly in combination with other antidiabetic agents
• Outline measures that can be taken to reduce medication errors in older adults wtih T2DM

To register, please visit www.gdmedicine.com/ASCP2011.

For more information on this activity contact Deanna N. Schuly at 215.321.3204 or email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Developed by Global Directions in Medicine, Inc.

Supported by an educational grant from Novo Nordisk Inc.

11:15 a.m. - 1:00 p.m.

Slowing Cognitive and Functional Decline in Alzheimer's Disease: Evaluating the Evidence

Activity # 0203-9999-11-116-L01-P; 1.5 contact hours

Speakers:

Gary W. Small, MD

Professor of Psychiatry and Biobehavioral Sciences

Parlow-Solomon Professor on Aging

David Geffen School of Medicine at UCLA

Bradley R. Williams, PharmD, FASCP, CGP

Professor of Clinical Pharmacy

Clinical Pharmacy and Pharmaceutical Economics & Policy

University of Southern California

Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that gradually destroys a person's cognitive abilities. Along with deterioration of cognitive function, nearly all individuals affected by AD also experience behavioral and neuropsychiatric disturbances, such as anxiety, depression, agitation, delusions, and hallucinations. The goal of this continuing education activity is to expand the ability of senior care pharmacists to optimize the management of AD in order to delay worsening of symptoms, preserve cognitive function, and help control behavioral symptoms, ultimately improving the quality of life for patients with AD.

Learning Objectives:

At the conclusion of this application-based activity the participant will be able to:

• Implement strategies to support accurate and early identification of patients with Alzheimer’s disease
• Describe the need for the stage-specific management of patients with Alzheimer’s disease
• Outline the optimal use of pharmacologic and non-pharmacologic approaches in the management of Alzheimer’s disease
• Recommend medication regimens to minimize polypharmacy and medication adverse events in patients who have moderate to severe Alzheimer’s disease

For more information on this activity contact Paula Dinote at 267.364.0556 x122 or email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Developed by Medical Communications Media

Supported by an educational grant from Forest Research Institute, Inc.